MARINUS PHARMACEUTICALS, INC. Accounts Receivable
MARINUS PHARMACEUTICALS, INC. had Accounts Receivable of $3.84 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2024-11-12
- 2024-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $3.84M.
- 2024-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $3.44M.
- 2024-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $3.51M.
- 2023-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $3.80M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2024-09-30 | $3.84M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.44M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $3.51M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.80M 10-Q · filed 2024-11-12 |
| 2023-09-30 | $4.28M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $5.23M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $11.69M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.35M 10-K · filed 2024-03-05 |
| 2022-09-30 | $3.40M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $3.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.49M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.63M 10-K · filed 2023-03-09 |
| 2021-09-30 | $2.47M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $1.65M 10-K · filed 2022-03-24 |